Personalis (PSNL) Financial Statements
Price: $3.275
Market Cap: $289.21M
Avg Volume: 1.05M
Market Cap: $289.21M
Avg Volume: 1.05M
Country: US
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Personalis.
Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $84.61M | $73.48M | $65.05M | $85.49M | $78.65M | $65.21M | $37.77M | $9.39M |
| Cost of Revenue | $57.79M | $55.27M | $51.70M | $53.84M | $58.53M | $43.13M | $25.97M | $11.74M |
| Gross Profit | $26.82M | $18.21M | $13.35M | $31.66M | $20.11M | $22.08M | $11.80M | $-2.34M |
| Gross Profit Ratio | 31.70% | 24.78% | 20.52% | 37.03% | 25.57% | 33.86% | 31.25% | -24.94% |
| Research and Development Expenses | $48.91M | $64.78M | $64.91M | $49.31M | $28.57M | $22.42M | $14.30M | $9.92M |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $11.27M | $9.90M |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $46.19M | $49.73M | $63.97M | $47.70M | $33.69M | $22.08M | $11.27M | $9.90M |
| Other Expenses | $- | $13.64M | $61.00K | $-42.00K | $-24.00K | $-1.44M | $-33.00K | $-227.00K |
| Operating Expenses | $95.09M | $128.14M | $128.88M | $97.01M | $62.26M | $44.50M | $25.57M | $19.82M |
| Cost and Expenses | $152.88M | $183.42M | $180.58M | $150.85M | $120.79M | $87.62M | $51.54M | $31.56M |
| Interest Income | $5.51M | $5.90M | $2.40M | $367.00K | $949.00K | $1.62M | $293.00K | $100.00K |
| Interest Expense | $24.00K | $110.00K | $201.00K | $184.00K | $2.00K | $1.13M | $1.89M | $1.30M |
| Depreciation and Amortization | $10.94M | $11.30M | $12.88M | $8.96M | $7.17M | $5.73M | $3.07M | $1.22M |
| EBITDA | $-70.30M | $-96.81M | $-104.64M | $-59.01M | $-34.05M | $-18.21M | $-14.92M | $-21.07M |
| EBITDA Ratio | -83.08% | -131.74% | -160.87% | -69.03% | -43.30% | -27.93% | -39.50% | -224.36% |
| Operating Income | $-68.27M | $-109.94M | $-115.53M | $-65.35M | $-42.15M | $-22.42M | $-13.77M | $-22.16M |
| Operating Income Ratio | -80.68% | -149.61% | -177.61% | -76.44% | -53.59% | -34.38% | -36.45% | -235.95% |
| Total Other Income Expenses Net | $-13.00M | $1.72M | $2.26M | $141.00K | $923.00K | $-2.66M | $-6.11M | $-1.43M |
| Income Before Tax | $-81.27M | $-108.21M | $-113.28M | $-65.21M | $-41.22M | $-25.07M | $-19.88M | $-23.59M |
| Income Before Tax Ratio | -96.04% | -147.27% | -174.14% | -76.28% | -52.41% | -38.45% | -52.63% | -251.18% |
| Income Tax Expense | $18.00K | $83.00K | $40.00K | $14.00K | $57.00K | $9.00K | $7.00K | $5.00K |
| Net Income | $-81.28M | $-108.30M | $-113.31M | $-65.23M | $-41.28M | $-25.08M | $-19.89M | $-23.60M |
| Net Income Ratio | -96.06% | -147.38% | -174.20% | -76.29% | -52.49% | -38.47% | -52.64% | -251.23% |
| EPS | $-1.37 | $-2.25 | $-2.48 | $-1.49 | $-1.06 | $-0.80 | $-0.91 | $-1.08 |
| EPS Diluted | $-1.37 | $-2.25 | $-2.48 | $-1.49 | $-1.06 | $-0.80 | $-0.91 | $-1.08 |
| Weighted Average Shares Outstanding | 59.25M | 48.18M | 45.70M | 43.89M | 39.11M | 31.24M | 21.75M | 21.75M |
| Weighted Average Shares Outstanding Diluted | 59.25M | 48.18M | 45.70M | 43.89M | 39.11M | 31.24M | 21.75M | 21.75M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $91.42M | $56.98M | $89.13M | $105.58M | $68.53M | $55.05M | $19.74M | $22.62M |
| Short Term Investments | $93.59M | $57.20M | $78.53M | $181.48M | $134.76M | $73.24M | $- | $- |
| Cash and Short Term Investments | $185.01M | $114.18M | $167.66M | $287.06M | $203.29M | $128.29M | $19.74M | $22.62M |
| Net Receivables | $8.14M | $17.73M | $16.64M | $18.47M | $6.35M | $3.30M | $4.46M | $1.94M |
| Inventory | $3.98M | $5.66M | $8.59M | $5.61M | $2.67M | $4.61M | $2.13M | $822.00K |
| Other Current Assets | $5.89M | $9.17M | $9.02M | $14.18M | $10.88M | $6.77M | $3.22M | $1.35M |
| Total Current Assets | $203.01M | $146.74M | $199.70M | $318.23M | $220.72M | $139.58M | $29.56M | $26.73M |
| Property Plant Equipment Net | $64.73M | $75.22M | $88.42M | $73.47M | $22.11M | $15.95M | $11.45M | $6.34M |
| Goodwill | $- | $- | $- | $- | $- | $- | $- | $- |
| Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Long Term Investments | $- | $1.79M | $1.79M | $- | $- | $- | $- | $- |
| Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Assets | $2.53M | $1.35M | $2.80M | $4.83M | $2.02M | $1.76M | $659.00K | $495.00K |
| Total Non-Current Assets | $67.25M | $78.36M | $93.00M | $78.30M | $24.12M | $17.71M | $12.11M | $6.84M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $270.27M | $225.10M | $292.70M | $396.53M | $244.84M | $157.29M | $41.67M | $33.56M |
| Account Payables | $6.40M | $14.92M | $12.85M | $9.22M | $8.30M | $7.34M | $6.57M | $4.04M |
| Short Term Debt | $9.37M | $9.41M | $7.61M | $5.53M | $2.44M | $1.36M | $5.00M | $17.51M |
| Tax Payables | $- | $37.00K | $123.00K | $121.00K | $95.00K | $210.00K | $181.00K | $108.00K |
| Deferred Revenue | $3.10M | $3.29M | $1.26M | $3.98M | $21.03M | $35.98M | $42.90M | $24.71M |
| Other Current Liabilities | $12.26M | $19.58M | $12.54M | $16.44M | $8.76M | $5.08M | $46.11M | $2.63M |
| Total Current Liabilities | $31.13M | $47.23M | $33.13M | $31.31M | $40.64M | $49.96M | $57.85M | $48.99M |
| Long Term Debt | $34.88M | $39.55M | $41.04M | $52.80M | $8.54M | $639.00K | $683.00K | $292.00K |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $1.30M | $8.87M | $389.00K | $2.12M | $720.00K | $- | $89.53M | $76.89M |
| Total Non-Current Liabilities | $36.19M | $48.42M | $41.43M | $54.91M | $9.26M | $639.00K | $90.21M | $77.18M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $67.31M | $95.66M | $74.56M | $86.23M | $49.90M | $50.60M | $148.06M | $126.17M |
| Preferred Stock | $- | $- | $- | $- | $- | $157.29M | $89.40M | $76.00M |
| Common Stock | $9.00K | $5.00K | $5.00K | $4.00K | $4.00K | $3.00K | $1.00K | $1.00K |
| Retained Earnings | $-549.99M | $-468.71M | $-360.41M | $-247.09M | $-181.87M | $-140.59M | $-115.50M | $-95.62M |
| Accumulated Other Comprehensive Income Loss | $-23.00K | $-222.00K | $-912.00K | $-166.00K | $22.00K | $-6.00K | $-15.00K | $-10.00K |
| Other Total Stockholders Equity | $752.96M | $598.36M | $579.46M | $557.56M | $376.79M | $247.28M | $-80.27M | $-72.97M |
| Total Stockholders Equity | $202.96M | $129.44M | $218.14M | $310.30M | $194.94M | $106.69M | $-106.39M | $-92.60M |
| Total Equity | $202.96M | $129.44M | $218.14M | $310.30M | $194.94M | $106.69M | $-106.39M | $-92.60M |
| Total Liabilities and Stockholders Equity | $270.27M | $225.10M | $292.70M | $396.53M | $244.84M | $157.29M | $41.67M | $33.56M |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $270.27M | $225.10M | $292.70M | $396.53M | $244.84M | $157.29M | $41.67M | $33.56M |
| Total Investments | $93.59M | $58.98M | $78.53M | $181.48M | $134.76M | $73.24M | $- | $- |
| Total Debt | $44.25M | $48.96M | $48.65M | $52.80M | $10.99M | $1.36M | $5.00M | $17.51M |
| Net Debt | $-47.17M | $-8.02M | $-40.48M | $-52.79M | $-57.54M | $-53.69M | $-14.75M | $-5.11M |
Cash Flow Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $-81.28M | $-108.30M | $-113.31M | $-65.23M | $-41.28M | $-25.08M | $-19.89M | $-23.60M |
| Depreciation and Amortization | $10.94M | $11.30M | $8.43M | $6.01M | $5.76M | $4.75M | $3.07M | $1.22M |
| Deferred Income Tax | $- | $- | $- | $2.03M | $391.00K | $3.11M | $4.47M | $226.00K |
| Stock Based Compensation | $10.69M | $14.05M | $19.43M | $14.38M | $8.24M | $4.86M | $1.32M | $753.00K |
| Change in Working Capital | $-2.59M | $13.48M | $10.61M | $-31.14M | $-17.23M | $-7.26M | $15.42M | $20.76M |
| Accounts Receivables | $9.59M | $-1.09M | $1.82M | $-12.12M | $-3.05M | $1.07M | $-2.52M | $-1.20M |
| Inventory | $4.42M | $-1.93M | $-2.98M | $29.00K | $-1.08M | $-1.17M | $-2.07M | $-539.00K |
| Accounts Payables | $-8.92M | $5.18M | $3.09M | $-1.46M | $751.00K | $1.40M | $2.16M | $2.63M |
| Other Working Capital | $-7.68M | $11.33M | $8.68M | $-17.60M | $-13.86M | $-8.56M | $17.84M | $19.87M |
| Other Non Cash Items | $17.10M | $13.21M | $4.61M | $3.12M | $1.47M | $1.56M | $1.18M | $934.00K |
| Net Cash Provided by Operating Activities | $-45.15M | $-56.26M | $-70.23M | $-70.83M | $-42.65M | $-18.07M | $5.57M | $290.00K |
| Investments in Property Plant and Equipment | $-1.60M | $-10.91M | $-49.90M | $-11.08M | $-3.25M | $-8.38M | $-7.85M | $-5.16M |
| Acquisitions Net | $- | $-24.01M | $-102.43M | $48.99M | $65.14M | $73.20M | $- | $- |
| Purchases of Investments | $-121.71M | $-103.94M | $-121.49M | $-267.13M | $-161.78M | $-78.90M | $- | $- |
| Sales Maturities of Investments | $88.00M | $127.95M | $223.92M | $218.14M | $99.88M | $5.70M | $- | $- |
| Other Investing Activities | $242.00K | $24.01M | $102.43M | $-48.99M | $-65.14M | $-73.20M | $- | $- |
| Net Cash Used for Investing Activities | $-35.07M | $13.10M | $52.54M | $-60.07M | $-65.14M | $-81.58M | $-7.85M | $-5.16M |
| Debt Repayment | $-1.13M | $174.00K | $-1.10M | $3.31M | $- | $-5.00M | $-645.00K | $16.40M |
| Common Stock Issued | $97.82M | $3.51M | $2.46M | $162.26M | $117.50M | $144.03M | $54.00K | $65.00K |
| Common Stock Repurchased | $- | $- | $- | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $17.98M | $7.34M | $2.46M | $4.13M | $3.77M | $-4.08M | $54.00K | $2.00K |
| Net Cash Used Provided by Financing Activities | $114.67M | $11.03M | $1.37M | $169.70M | $121.27M | $134.95M | $-591.00K | $16.40M |
| Effect of Forex Changes on Cash | $-22.00K | $-16.00K | $-127.00K | $47.00K | $7.00K | $2.00K | $-2.00K | $4.00K |
| Net Change in Cash | $34.43M | $-32.14M | $-16.46M | $38.85M | $13.48M | $35.30M | $-2.87M | $11.54M |
| Cash at End of Period | $93.20M | $56.98M | $90.92M | $107.38M | $68.53M | $55.05M | $19.74M | $22.62M |
| Cash at Beginning of Period | $58.77M | $89.13M | $107.38M | $68.53M | $55.05M | $19.74M | $22.62M | $11.08M |
| Operating Cash Flow | $-45.15M | $-56.26M | $-70.23M | $-70.83M | $-42.65M | $-18.07M | $5.57M | $290.00K |
| Capital Expenditure | $-1.60M | $-10.91M | $-49.90M | $-11.08M | $-3.25M | $-8.38M | $-7.85M | $-5.16M |
| Free Cash Flow | $-46.75M | $-67.17M | $-120.13M | $-81.91M | $-45.90M | $-26.45M | $-2.28M | $-4.87M |